טוען...
PDCT-23. PROLIFERATION INDEX INFLUENCES INITIAL RESPONSE PATTERN OF PEDIATRIC HIGH-GRADE GLIOMAS TREATED WITH HSV-1 G207 ONCOLYTIC VIROTHERAPY
Genetically engineered oncolytic HSV-1 G207, which lacks genes essential for replication in normal brain, is currently being studied in a first-in-human children clinical trial of intratumoral virus inoculation in recurrent or progressive supratentorial malignant tumors. We describe the initial patt...
שמור ב:
| הוצא לאור ב: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5691980/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.764 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|